Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) in Patients With Acromegaly in Colombia
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Sleep apnea/hypopnea syndrome (SAHS) affects over half of acromegaly patients, linked to longer disease duration and higher IGF-1 levels. Early diagnosis and treatment are crucial for managing this common comorbidity.
Area Of Science
- Endocrinology
- Sleep Medicine
- Cardiovascular Disease
Background
- Acromegaly, a rare disorder from excess growth hormone (GH), affects ~5 per million annually.
- Sleep apnea/hypopnea syndrome (SAHS) impacts up to 80% of acromegaly patients.
- SAHS is an independent risk factor for cardiovascular disease.
Purpose Of The Study
- To determine the prevalence of SAHS in Colombian acromegaly patients.
- To identify factors associated with SAHS in this population.
Main Methods
- Observational, retrospective cohort study using the National Registry of Patients with Acromegaly (RAPACO).
- Inclusion criterion: baseline polysomnography (PSG).
- 163 patients evaluated.
Main Results
- 54.6% of patients (89/163) were diagnosed with SAHS.
- OSAHS patients had higher BMI, longer disease duration, and elevated IGF-1 and GH levels (p=0.006, p=0.027).
- Multivariate analysis linked disease duration and IGF-1 levels to SAHS.
Conclusions
- SAHS is a highly prevalent comorbidity in acromegaly patients.
- Hormonal factors, particularly elevated IGF-1 and GH, are critical in SAHS pathogenesis.
- Routine PSG screening for SAHS in acromegaly patients is recommended.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
• Chronic Cough: A persistent cough, often productive, is a crucial symptom of COPD.
•...
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Primary Step: The most critical intervention for all COPD patients who smoke.
Benefits: Slows disease...